{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Glasgow",
      "address_1": "1220 N Race St",
      "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.",
      "address_2": "",
      "product_quantity": "1 vial",
      "code_info": "Lot #: 071714A",
      "center_classification_date": "20141219",
      "distribution_pattern": "KY",
      "state": "KY",
      "product_description": "Hydroxyprogesterone Caproate, 250 mg per mL, 5 mL vial, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141",
      "report_date": "20141231",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Vann Healthcare Services Inc",
      "recall_number": "D-0309-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "69633",
      "termination_date": "20150701",
      "more_code_info": "",
      "recall_initiation_date": "20141014",
      "postal_code": "42141-3462",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}